Univariable analyses
| hs-CRP | hs-TnT | |||||||||
| Referents | Cases | All, OR (95% CI) | No CAD, OR (95% CI) | CAD, OR (95% CI) | Referents | Cases | All, OR (95% CI) | No CAD, OR (95% CI) | CAD, OR (95% CI) | |
| Q1 | 164 | 70 | 1.00 | 1.00 | 1.00 | 248 | 92 | 1.00 | 1.00 | 1.00 |
| Q2 | 163 | 58 | 0.86 (0.57 to 1.30) | 0.54 (0.28 to 1.04) | 1.20 (0.69 to 2.08) | 77 | 39 | 1.54 (0.96 to 2.47) | 1.17 (0.56 to 2.43) | 1.88 (1.00 to 3.54) |
| Q3 | 160 | 89 | 1.35 (0.91 to 2.01) | 0.96 (0.52 to 1.74) | 1.85 (1.08 to 3.18) | 161 | 81 | 1.65 (1.10 to 2.47) | 1.46 (0.79 to 2.69) | 1.88 (1.08 to 3.26) |
| Q4 | 160 | 93 | 1.40 (0.94 to 2.06) | 0.99 (0.55 to 1.80) | 1.79 (1.05 to 3.05) | 161 | 98 | 2.20 (1.43 to 3.40) | 2.09 (1.04 to 4.17) | 2.29 (1.29 to 4.07) |
| Z-scores | ||||||||||
| All (missing) | 646 | 310 | 1.13 (0.98 to 1.30) | 0.97 (0.78 to 1.21) | 1.24 (1.03 to 1.50) | 646 | 310 | 1.27 (1.10 to 1.47) | 1.40 (1.07 to 1.83) | 1.20 (1.01 to 1.43) |
| All | 671 | 336 | 1.13 (0.98 to 1.30) | 0.98 (0.79 to 1.21) | 1.24 (1.03 to 1.48) | 671 | 336 | 1.24 (1.07 to 1.43) | 1.39 (1.06 to 1.82) | 1.17 (0.98 to 1.38) |
| Men | 349 | 175 | 1.12 (0.92 to 1.37) | 0.83 (0.59 to 1.17) | 1.28 (1.00 to 1.64) | 349 | 175 | 1.29 (1.05 to 1.57) | 1.61 (1.04 to 2.50) | 1.19 (0.94 to 1.49) |
| Women | 322 | 161 | 1.14 (0.94 to 1.38) | 1.08 (0.82 to 1.43) | 1.19 (0.91 to 1.55) | 322 | 161 | 1.19 (0.97 to 1.45) | 1.27 (0.91 to 1.78) | 1.14 (0.88 to 1.47) |
| Surgery <5 years | 148 | 74 | 0.96 (0.69 to 1.34) | 0.81 (0.50 to 1.33) | 1.03 (0.64 to 1.65) | 148 | 74 | 1.57 (1.21 to 2.05) | 1.97 (1.24 to 3.15) | 1.34 (0.99 to 1.81) |
| Surgery ≥5 years | 523 | 262 | 1.17 (1.00 to 1.37) | 1.03 (0.80 to 1.31) | 1.27 (1.05 to 1.55) | 523 | 262 | 1.06 (0.88 to 1.28) | 1.01 (0.68 to 1.50) | 1.08 (0.86 to 1.34) |
Values are the ORs with (95% CIs) for 1 (ln) SD increase (z-score) in the hs-CRP level or the hs-TnT level, as indicated. Z-scores with missing values replaced were used for all univariable calculations except when indicated.
Stratification for presence of CAD (yes/no), sex (men and women) and time between survey and surgery (less or more than 5 years).
Cut-offs for the quartiles (Q1–Q4) were: hs-CRP (mg/L; men and women): 0.5, 1.0, 2.5 and 0.6, 1.2, 2.3, respectively.
hs-TnT (ng/L; men and women combined) were 3.0, 3.7, 5.4. P values for indicating a trend: 0.026 for hs-CRP and 0.006 for hs-TnT.
CAD, coronary artery disease; hs-CRP, high-sensitivity C reactive protein; hs-TnT, high-sensitivity troponin T.